BioCentury
ARTICLE | Finance

Sweden heating up

How private money and retail investors are fueling Stockholm’s biotech IPO boom

April 22, 2017 2:16 AM UTC

Following a nearly 15-year deep freeze, Stockholm has become one of the hottest European markets for biotech IPOs. The recent boom reflects a ripening of several years of investment in the early stage life sciences ecosystem that has coincided with a risk-on mentality among Sweden’s large, wealthy retail investor base. Local VCs and bankers say there are more to come.

Beginning in 2010, VCs and institutions set to work building a second-generation biotech ecosystem in Scandinavia intended to create sustainable companies that could attract global capital...